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Abstract 
 Continuous glucose monitoring via implantable glucose sensors has been considered for precise 
and timely measurement of the blood sugar level for diabetes regulation. The foreign body response 
(FBR) from the tissue to implanted objects at the insult site poses challenges in maintaining the 
analytical performances of sensors by either blocking or consuming local glucose around the site of 
implantation. Macrophages are essential immune cells and regulators in the FBR and can consume 
enough glucose, depending on polarization states, to interfere with glucose measurements. To provide 
an approach to further understand macrophages’ role and impact in FBR, a glucose consumption 
sensing platform composed of an in-house fabricated implantable glucose sensor and cell-embedded 
fibrin gels was used to provide a current signal decay that was related to the glucose concentration 
change in the gels. Though sensor sensitivity and dynamic ranges were acceptable, yet results from 
obtained macrophage-embedded gels were not significantly different among different cellular 
conditions. These findings were likely caused by protein-sensor interaction in the gels and potential in 
both gel preparation and operation on cells. Such results reveal some shortcomings of the applied 
platform and express the necessity in refining the platform design and in regulating the interaction 
between the sensor surface and substances from gels and from other parts of the sensing platform to 
achieve the full potential in quantification that was proposed for such design. 
 
Introduction 
 Diabetes is a disease characterized by insufficient blood sugar management via insulin, where the 
body either cannot produce insulin (type I) or cannot properly respond to it (type II). Failure to regulate 
blood sugar leads to adverse health effects, from acute ones, such as loss of consciousness, to chronic 
complications, including blindness and renal failure.1 With 34.2 million diagnosed diabetes patients in 
 
the United States in 2018, according to the recent statistics of Centers for Disease Control and 
Prevention (CDC)2, this population is predicted to rise to 44.1 million by 2034.3 Due to its prevalence, 
diabetes has become a critical concern in public health, and the need for successful diabetes treatment 
for patients keeps increasing. 
Accurate blood sugar monitoring is necessary for the treatment of type I diabetes to identify 
hyperglycemia when insulin injection is necessary and hypoglycemia due to the disrupted blood sugar 
regulation or due to over injection of insulin. To this aim, continuous glucose monitoring (CGM) is 
preferred over the discrete measurements of finger prick glucometry, as it provides dynamic 
quantification of the blood sugar levels and records sharp changes in glycemia that can otherwise be 
missed between discrete measurements and detrimentally affect patients. To achieve CGM for diabetes 
patients, implantable electrochemical sensors, utilizing the enzyme glucose oxidase (GOx) for indirect 
detection of glucose, have been developed and applied for decades. Compared with others CGM 
approaches, such as optical CGM systems, electrochemical CGM approaches do not need to include 
precise alignment of components as optical components needs and do not need to store dyes and 
chemicals that prevent the reversibility of the enzymatically catalyzed reactions involving local 
glucose and result in color changes to be detected by the optical system.4  
However, the foreign body response (FBR) has been identified as negatively affecting sensor 
performance and lifespan. The foreign body response is the stepwise tissue immune activity due to 
frustrated wound healing caused by the continuous presence of implanted foreign objects. In the FBR 
process, proteins start to accumulate on the surface of the implanted object immediately after the 
implantation. Later, cells including macrophages, fibroblasts, and monocytes aggregate around and try 
to remove the implanted object, meanwhile releasing mediators to recruit more cells for such response. 
 
Such intensive cellular response consumes local glucose to form a metabolic barrier that blocks the 
glucose diffusion to the sensor and alters the chemical environment that may interfere with sensor 
operation. Finally, weeks after the initial implantation, collagen can accumulate around the sensors, 
forming layers that physically block the glucose diffusion to the implanted sensor.5 Among the glucose 
consuming cells in the FBR, macrophages as an important immune response cells aggregate around 
the implanted object perform vigorous activities such as attempting phagocytosis5 and consume a large 
amount of glucose for its activities.6  
Such glucose consumptive nature of macrophages around sensors negatively affects the accuracy 
of CGM, yet the rate of macrophage glucose consumption is variable for different conditions. It has 
been known that macrophages, responding to environmental triggers, can be polarized to different 
phenotypes or activation states, among which are pro-inflammatory states, more associated with host 
defense and anti-inflammatory states, more related to wound healing.7 Pro-inflammatory macrophages 
have higher expression of the GLUT1 glucose transporter, leading to their higher glucose consumption 
rates, while the anti-inflammatory macrophages have lower glucose consumption rates compared with 
those inactivated.8-10 Therefore, altering the activation state of the macrophage around the sensors have 
been pointed out as a possible approach to mitigate part of the FBR to the implanted glucose sensors 
for improving sensor performance and prolonging their lifespan with acceptable accuracy.5,9 For 
instance, nitric oxide (NO), an endogenous gaseous molecule that can be produced by anti-
inflammatory macrophages, more intensively in early-stage wounds,11 involves in inflammation and 
wound healing regulation and has been shown to lessen the FBR response. Nitric oxide-releasing 
sensors (NO-releasing sensors) have been shown with improved sensitivity and accuracy during in 
vivo implantations, with the duration of such improvement correlated with the time length of the NO 
 
release12,13 together with the observation of less inflammatory cells and less dese collagen capsules 
around sensors as evidence of mitigated FBR.13 The dependence of presence and time profile of NO 
release with sensor performance improvement shows the role of NO release in such advancement in 
CGM, and macrophage activation state alternation is hypothesized as a part of the mechanism of this 
improvement under NO release. 
Under the knowledge of macrophages and its role in FBR process with its possible roles and 
changes in NO mitigated FBR, the glucose consumption profile of macrophages themselves as an 
individual FBR participator has been focused for the overall interest of understanding FBR and 
providing CGM sensors with longer lifespan and better performance stability in tissues. Novak et al. 
have reported the cell-embedded fibrin gel model as simulated early-stage inflammatory cells 
aggregation sites for understanding the macrophage inflammation effects on the sensor implanted into 
the gel, pointing out the dependence of signal decline recorded by sensors with cell type and activation. 
The normalized current magnitude decay in gel with 1μg/mL lipopolysaccharides (LPS) stimulated 
cells or with 50 nM phorbol 12-myristate 13-acetate (PMA) stimulated cells was significant from and 
about three times more than that observed in unstimulated macrophage-embedded gels, showing 
evidence of more intensive glucose consumption in macrophages stimulated to pro-inflammatory 
states6.  
This work utilized the sensing platform composed by the macrophage-embedded fibrin gels as a 
simulation of implantation wound site at the end of its inflammation while before the formation of 
encapsulating coating6,14 and in-house fabricated needle-type implantable glucose sensors15 that has 
been shown as successful to differentiate macrophage glucose consumption profiles under different 
phenotype, hoping to quantify the difference in such profiles. Macrophages unstimulated and 
 
stimulated to pro-inflammatory states were compared to measure the contribution of different 
macrophage activities in the glucose depletion around the sensor implanted in the fibrin gel. From the 
results, the sensing platform's ability to understand macrophage glucose consumption and contribution 
for the breakdown investigation of FBR and platform’s ability to test the influence of approaches 
considered as FBR mitigating on macrophage glucose consumption activities was evaluated. 
 
Experimental 
 Sensor fabrication. Implantable glucose sensors were using a first-generation glucose sensor 
design, as shown in Figure 1. The working electrode of the sensor was made from 
polytetrafluoroethylene (PTFE) coated platinum-iridium (Pt-Ir) wire with a diameter of 127 μm, with 
a cylindrical surface of ~3 mm length at the end exposed as the electrode surface by burning off the 
PTFE coat. The Ag/AgCl reference electrode was prepared from a silver wire coil treated with 
saturated FeCl3 (aq.) for 40 min. Electrodes were then coated with three distinct layers. The innermost 
one was an m-phenylendiamine (m-PD) size-selective layer on the working electrode for interferent 
exclusion. It was electropolymerized onto the working electrode using cyclic voltammetry between 0 
and 1 V vs. Ag/AgCl for 20 cycles with a 100 mV/s scan rate in 0.1 M m-PD solution in 1X phosphate 
buffer saline (PBS). The second layer was glucose oxidase (GOx) immobilized in a silica sol-gel. The 
glucose oxidase can catalyze the oxidation of glucose and produce electrochemically active hydrogen 
peroxide, detectable by the electrode to facilitate indirect glucose quantification. The sol-gel layer was 
added by dipping m-PD incorporated electrodes in a mixture of 100 μL ethanol, 25 μL 
methyltrimethoxysilane (MTMOS), 50 μL water, and ~ 0.6 mg GOx (derived from Aspergillus niger). 
Each electrode was dipped in the sol-gel mixture 15 times, with 5 s hold time each and 10 s rest time 
 
between each dip. The outermost layer was a polyurethane sheath (PU) controlling the diffusion of the 
glucose to limit glucose diffusion to the electrode and resulting in a linear correlation between current 
and glucose concentration of the environment. The polyurethane HP-93A-100 was dissolved into 
solution by sonication in 3:1 tetrahydrofuran/N, N-dimethylformamide at 60 ℃ to 50 mg/mL, and was 
casted onto the GOx-coated sensor by a wire loop. A PU topcoat (30 mg/mL PC 3585A) was dip casted 
for the topcoat of the sheath to limit the glucose diffusion and to extend the linear dynamic range (LDR) 
of sensors. Fully coated sensors were dried at 4 ℃ for ~ 1 h and then hydrated and preconditioned in 
1X PBS before usage. 
 
Figure 1: Structure, dimension, and coating design of the used implantable glucose sensors. The 
polyurethane layer controls the glucose diffusion from the surrounding, the GOx layer catalyzes 
glucose conversion to hydrogen peroxide, and the size-selective layer selected targeted hydrogen 
peroxide from interferents. 
Sensor performance testing. Glucose calibration in 1X PBS at room temperature was performed 
by amperometric measurement at +0.6 V vs. Ag/AgCl to investigate sensor performance. Calibration 
in 10% fetal bovine serum (FBS) in 1X PBS was also performed to show the effect of protein 
biofouling on sensor performance. Calibrations at 37 ℃ in 1X PBS and 10% fetal bovine serum (FBS) 
in 1X PBS were performed and compared with room temperature calibration to reveal whether 
operation at physiological temperature was necessary for achieving desired sensor performance. 
 
 Preparation of fibrin gel and treatment to macrophages. Fibrin gels were prepared by mixing 480 
μL 1 1X DMEM media, 200 μL 2X DMEM media with 4.5 g/L glucose, 200 μL 10 mg/mL fibrinogen, 
100 μL murine matrigel, and 20 μL 1.04 mg/mL thrombin. The mixture was heated to 37 ℃ for 30-45 
minutes to achieve solidification. To create macrophage-embedded gels, RAW 264.7 murine 
macrophages were suspended in the 480 μL of 1X DMEM to obtain a concentration of 4.2×106 
cells/mL of DMEM, for a final gel concentration of 2 x 106 cells/mL, considered as the typical 
histological density of inflammatory cells in an inflammation/wound healing site.6 This same protocol 
was adapted to create gels of inflammatory cells at the same cell density of inflammation and wound 
healing sites.16 Dead macrophages were prepared by bathing the cell suspension in boiling water for 
more than 5 min, and pro-inflammatory macrophage-embedded gels were prepared by stimulating the 
cells with 1 μg/mL LPS for 24 h before the suspension. 
 Sensor Implantation in gels and data analysis. As shown in Figure 2, prepared gels were 
submerged in 10 mL medium. The medium was varied from glucose-free 1X PBS, 10% FBS in 1X 
PBS, and 1X DMEM with 1g/L (5.56 mM) glucose for comparison of sensor performance stability in 
the platform without cell introduction, and was varied from 1X PBS and 1X DMEM, both at 5.56 mM 
glucose, for confirming the medium compatibility to the sensing platform with cell-embedded gels. 
Sensors were inserted into submerged gels to simulate an implantation site and amperometric 
measurements at +0.6 V vs. Ag/AgCl for at least 24 h were performed. For the study of sensor 
performance stability, sensors were calibrated before and after the implantation to compare 
performances. The trace of current recorded was considered as a reflection of glucose concentration 
change in the gel during the process of implantation, with a current magnitude decay associated with 
glucose concentration decrease. The decay in current magnitude for the first 4 h of the implantation 
 
was considered as uniquely due to electrode polarization, and thus the amperogram was normalized 
by reporting the ratio of the measured current to the current measured at 4 h (i/i4h). The range of error 
of current measured in each particular experimental condition and the time dependence of such error 
range were determined by the standard deviation of the i/i4h provided by trials with different sensors. 
 
Figure 2: Schematic layout of the sensing platform with media submerged cell-embedded gel 
implanted with a glucose sensor. The media varied from 1X DMEM with 1g/L (5.56 mM) glucose and 
1X PBS with the same glucose concentration in the study for comparison. 
 
Results 
 Optimization of sensor preparation. Varied coating compositions different in the presence of the 
size-selective layer and the composition/type of the PU sheath were tried with their performance 
characterized. A linear dynamic range (defined as R2≥0.990) of at least 0-6 mM was preferred, to 
accommodate the initial 5.56 mM glucose concentration of the gel submerging medium at its highest. 
As macrophages will consume the glucose, the glucose concentration in the submerging media would 
only decrease and thus fall in a linear range of 0-6 mM at all times. Table 1 shows the sensitivity and 
linear dynamic ranges (LDR) obtained among sensors with the difference in the presence of the m-PD 
size-selective layer and the thickness of the PU sheath during the sensor optimization study. Since the 
 
case with 7×6.5 μL×50 mg/mL HP-93A-100 and presence of the m-PD layer had a wider linear 
dynamic range and satisfied the minimum linear dynamic range expectation, such composition of the 
electrode coating was determined as the optimized sensor design. 
 Preconditioning of the sensor coating in proteinaceous media was shown to stabilize sensor 
sensitivity and linear dynamic range along days when sensors were left in 10% FBS in 1X PBS either 
under 4 ℃ or 37 ℃. Cases of storing and calibrating at 37 ℃ were presented in Figure 3 as the 
representative results to show such stabilization. Sensor stabilization was also performed at 4 ℃ 
storing and room temperature calibrations (data not shown) and no significant difference was observed, 
and therefore the following experiments did not have heating associated. 
HP-93A-100 amount 
(1x = 6.5 μL×50 mg/mL) 
m-PD selective 
layer 
linear dynamic range 
(mM) 
sensitivity (nA/mM) 
3x not used 5.7±0.5 11.0±3.3 
7x not used 6.0±1.0 7.6±1.6 
7x used 7.8±2.6 5.14±3.51 
Table 1: Result of in-house fabricated implantable sensor design optimization. Sensitivity reported for 
7x HP-93A-100 cases was calculated based on cases with a linear range wider than 6 mM. All cases 
had PC-3585A topcoat included. 
  
Figure 3: Sensor performance, shown by calibration in 10% FBS in 1X PBS at 37 ℃, changed in 
consecutive days when the sensors were stored in 10% FBS in 1X PBS at 37 ℃, showing the sensitivity 
and linear dynamic range stabilizing in most of the trials obtained. Each color trace represents a trial 
of an individual sensor. 


























































performance was measured by comparing the calibrations of the same sensor before and after the 
implantation in gels. With the design of the fibrin gel kept constant, media with different compositions 
and therefore varied interactions and reactions with gels and implanted sensors from protein biofouling 
to additional electrochemically active species presence were compared with each other to evaluate the 
impact on the stability of the sensor performance. It was observed that though linear dynamic range 
did not change much during the implantation and was not very different across the gel submerging 
media tested, the sensitivity of the sensors was subjected to significant loss and the extent of that loss 
was dependent on the media chosen. As shown in Table 2, the simplest 1X PBS, which contained no 
proteins for biofouling and no other electrochemically active interferents, mitigates the loss of 
sensitivity when compared with FBS dilution where proteins persisted and with DMEM where more 
ingredients such as phenol red and sodium pyruvate involved. 
Gel submerging media Sensitivity change Linear range change (mM) 
1X PBS -33±49% +2.00±2.31 
10% FBS in 1X PBS -42%±16% +1.20±1.64 
1g/L glucose 1X DMEM -79%±6% +1.25±4.27 
Table 2: Sensitivity and linear dynamic range change in in-house fabricated implantable glucose 
sensors before and after being implanted and run for 24 h in cell-free fibrin gels submerged in different 
media. For condition reported, n = 3. 
Also, from the comparison between macrophage-embedded gels submerged in 1X DMEM with 
1g/L glucose and in 1X PBS with 1 g/L glucose, as shown in Figure 4, the current magnitude decay in 
gels with macrophages-embedded was more significant than gels without cell as expected when 1X 
PBS with 1g/L glucose was selected though with error region overlaid, yet the opposite was observed 
when 1X DMEM was used. Therefore, the media used in the gel-sensor sensing platform was changed 





Figure 4: current decay in cell-free fibrin gels (blue) and in macrophages-embedded gels (orange) 
with their standard deviation among trials as error range (shaded) when 1X DMEM (up) or 1X PBS 
with 1 g/L glucose (down) was selected as the gel submerging media to supply the glucose for cellular 
consumption. 
 Gels with macrophages heated to death were also tried to observe whether they could provide 
better controls against unstimulated macrophage-embedded gels. However, responses obtained in dead 
macrophage-embedded gels were not stabilized between cases and had a large error range. Therefore, 
dead macrophage-embedded gels used did not serve and was not selected as better controls to 
macrophage-embedded gels (Figure 5). 
 
 
Figure 5: Current monitored in gels embedded with dead macrophages and with standard deviation 
among trials as error range (shaded). 
 
Figure 6: Current monitored in gels embedded with unstimulated macrophages and with 1 μg/mL LPS 
stimulated macrophages with their standard deviation among trials as error range (shaded). The LPS 
stimulated trials had current decay that unexpectedly less significant when compared with trials with 
unstimulated macrophages. 
 Comparison between native and polarized macrophages. With the modified sensing platform, in 
which fibrin gels are submerged in glucose concentration adjusted 1X PBS, unstimulated macrophages 
and those stimulated by 1 μg/mL LPS for 24 h to pro-inflammatory states were interrogated. However, 
though pro-inflammatory macrophages are recognized to consume more glucose,8,9 a large current 
decay representative of glucose depletion was not observed in those pro-inflammatory macrophages, 
 
as shown in Figure 6. 
. 
Discussion 
 The optimization in sensor fabrication and preparation were mainly focused on the width of linear 
dynamic range to accommodate the possible glucose concentration range, with its higher-end at 5.56 
mM as the initial glucose concentration from which macrophages started to consume in the sensing 
platform during the course of sensor implantation and current monitoring. The size-selective layer 
composed by electropolymerized m-PD was blocking interference from reaching the working electrode 
and being oxidized15 and was used to achieve the consistency in the sensor design and its wider linear 
dynamic range reported in Table 1, though selectivity against commonly considered interferents for 
such electrode setups such as ascorbic acid, cysteine, and acetaminophen17 were not quantified in this 
study. Polyurethane HP-93A-100 was used for its hydrophilic nature that promoted glucose diffusion, 
and the PC-3585A topcoat, which was hydrophobic with minimum water uptake,15 was applied to limit 
the water uptake and therefore permeability of glucose, making the available concentration of glucose 
limited and rate-determining in the GOx catalyzed reaction, resulting in the reaction rate and monitored 
current that are glucose concentration proportional. Also, at a cost of signal sensitivity, this coating 
design with controlled and limited glucose diffusion avoided saturation and provided wider LDRs, 
which was the performance with priority for sensor application in this sensing platform. 
 Fibrin gels were implemented to simulate an implantation site at its late stage of inflammation in 
terms of inflammatory cell density and protein presence around the sensor,6 while as shown in Table 
2, among all media chosen to submerge the gels, sensitivity degradation of sensors during the 
implantation was significant. A hypothesis of linear sensitivity degradation, in which the sensitivity 
(slope) and intercept of the calibration equation have a decrease linearly over the experiment run time, 
 
was tried but did not yield a reasonable solution to concentration change in gels by presenting 
unexpected peak and later increase in glucose concentration (Figure 6). Proteins in solution readily 
attached to the surface of the sensor coating, blocking the diffusion of glucose and resulting in less 
current response to the same glucose concentration. This biofouling process was nonlinear18 and made 
direct tracking of sensitivity and calibration equation change difficult. Though it has been shown by 
literature19 that aqueous proteinaceous environment was not able to effectively block the glucose 
diffusion to sensors in long-term (16 h) use, the influence of protein from a fibrin gel setting to the 
sensitivity retention of sensors was not considered in its original application.6 Such findings limit the 
quantification ability of the sensing platform, making the comparison of glucose concentration change 
profiles in fibrin gels with various cellular conditions a qualitative one focusing on the relative 
magnitude and error range overlap instead of a quantitative one that identifies the real-time glucose 
concentration in the gels and is hoped for. Also shown in Table 2 as the medium dependence of such 
sensitivity loss, when compared with 1X PBS, the introduction of proteins in 10% FBS lead to slightly 
larger degradation, and inclusion of phenol red and other ingredients in DMEM significantly further 
worsen the sensitivity retention. As discussed for sensitivity retention of sensors themselves, aqueous 
proteinaceous media (10% FBS in 1X PBS) did not more significantly affect the sensitivity stability 
when compared with 1X PBS without other ingredients, and such result is comparable with the 
observation in the retention of performance during the implantation. However, the composition of 
DMEM and the presence of phenol red that is electrochemically active at the applied potential 
window20 affected sensing ability, expressed both in significant sensitivity loss and in current 
magnitude decay amount inversion from the expectation in the comparison between acellular gels 
control and macrophage-embedded gels. 
 
 
Figure 6: A set of typical predicted glucose concentration changes in the sensing platform with various 
gel submerging media and without cells using the time-proportional sensitivity and intercept change 
model. The concentration predicted decreased first while increased later instead of keeping constant 
as expected, showing the flaw in such a concentration prediction model. 
 Though gels with macrophages heated to death were tried, significant current decay corresponding 
to glucose consumption in some trials and therefore large error range associated with heated 
macrophage-embedded gels indicated that the killing mechanism adopted was not consistent, to be 
confirmed by viability testing had experiments were not terminated by the public health situation. As 
a result, cell-free gels, instead of gels with heated macrophages, were chosen as the control to compare 
with unstimulated macrophage-embedded gels. The obtained current decays in gels, among cell-
embedded cases and cell-free control cases and among stimulated and unstimulated macrophage cases, 
did not match with expectation. Cell-embedded gels had average current decay that was more 
significant than cell-free control gels as the result of cellular metabolism, yet their error ranges did not 
separate from each other. Such inability in differentiation is mostly considered as the result of large 
error ranges among the cell-free control cases, which may be contributed by inconsistency among 
prepared gels in terms of size and structural strength that lead to differences in glucose diffusion from 
the medium to the gels. On the other hand, gels containing LPS-stimulated macrophages, which are 
 
expected to be pro-inflammatory and consume more glucose, did not yield more significant current 
magnitude decay when compared with unstimulated macrophage-embedded gels. Uncertainty on the 
quality of such polarization persists, and alternative polarization methods or efforts in confirming the 
result of macrophage activation after stimulation can be implemented.  
For future directory in improving the quantification ability of the sensing platform, investigation 
of the actual sensitivity change profile during the sensor implantation in gel experimentally can be 
attempted. Besides, with previous knowledge of the actual concentration change in the platform via 
other approaches such as test strips, mathematical models simulating the current decays and supplying 
the experimental and numerical time-dependence of the sensitivity change can also be tried to 
investigate the sensitivity retention process in the platform. 
 
Conclusions 
 Up to this point, the application of sensors yielded acceptable results in performances, yet the 
incorporation of the fibrin gel as a simulation of early-stage implantation led to result out of expectation, 
expressing the difficulty to consider in accurately detecting glucose concentration with this setup. With 
the problems attributed to various issues in gels from protein adhesion to structural consistency, the 
effort for improving this platform should possibly be directed to better understanding the process that 
sensors experience in the gels and to quantify the change in performances during the implantation. The 
cellular study involved will also be subjected to restudy to improve consistency and to check whether 
the observed result mismatch is dependent on the incompatibility of sensors with the environments. In 
summary, this study pointed out problems that persist in the used sensing platform, and represent the 
needs to further investigate and modify this platform design for macrophage glucose consumption 
 
study for a part of FBR understanding and potentially for other cellular metabolisms with cells and 
substrates suitable for gel embedding and electrochemical detections. 
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